about
Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple SclerosisKynurenine pathway metabolites and suicidalityNeural and mesenchymal stem cells in animal models of Huntington's disease: past experiences and future challengesThe role of inflammation in suicidal behaviourToxin-Induced Experimental Models of Learning and Memory ImpairmentThe kynurenine pathway activities in a sub-Saharan HIV/AIDS populationXanthurenic acid binds to neuronal G-protein-coupled receptors that secondarily activate cationic channels in the cell line NCB-20Biochemical, histopathological and morphological profiling of a rat model of early immune stimulation: relation to psychopathologyQuinolinic Acid Responses during Interferon-α-Induced Depressive Symptomatology in Patients with Chronic Hepatitis C Infection - A Novel Aspect for Depression and Inflammatory HypothesisQuinolinic acid injection in mouse medial prefrontal cortex affects reversal learning abilities, cortical connectivity and hippocampal synaptic plasticityDiminished brain resilience syndrome: A modern day neurological pathology of increased susceptibility to mild brain trauma, concussion, and downstream neurodegeneration.Microglia of prefrontal white matter in suicideKynurenine pathway inhibition as a therapeutic strategy for neuroprotection.Kynurenines: from the perspective of major psychiatric disorders.Microglial dysregulation in psychiatric diseaseExcitotoxic brain injury in adult zebrafish stimulates neurogenesis and long-distance neuronal integration.Involvement of the kynurenine pathway in human glioma pathophysiology.Metabolic profiling of alternative NAD biosynthetic routes in mouse tissuesExpression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brainQuinolinic acid toxicity on oligodendroglial cells: relevance for multiple sclerosis and therapeutic strategies.Specific reactions of different striatal neuron types in morphology induced by quinolinic acid in rats.Multiethnic genome-wide association study of cerebral white matter hyperintensities on MRIActivation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.Expression of the Kynurenine Pathway in Human Peripheral Blood Mononuclear Cells: Implications for Inflammatory and Neurodegenerative DiseasePotential role of Plasmodium falciparum-derived ammonia in the pathogenesis of cerebral malariaTargeted plasma metabolome response to variations in dietary glycemic load in a randomized, controlled, crossover feeding trial in healthy adultsThe Isotropic Fractionator as a Tool for Quantitative Analysis in Central Nervous System DiseasesKynurenine pathway metabolism following prenatal KMO inhibition and in Mecp2(+/-) mice, using liquid chromatography-tandem mass spectrometry.Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patientsInteractions between inflammatory mediators and corticosteroids regulate transcription of genes within the Kynurenine Pathway in the mouse hippocampus.Characterization of the kynurenine pathway and quinolinic Acid production in macaque macrophages.Connecting inflammation with glutamate agonism in suicidality.Pentamidine analogs as inhibitors of [(3)H]MK-801 and [(3)H]ifenprodil binding to rat brain NMDA receptors.Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation.An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammationImmunomodulatory Factors Galectin-9 and Interferon-Gamma Synergize to Induce Expression of Rate-Limiting Enzymes of the Kynurenine Pathway in the Mouse Hippocampus.Progesterone Alters Kynurenine Pathway Activation in IFN-γ-Activated Macrophages - Relevance for Neuroinflammatory Diseases.3-hydroxi-anthranilic acid is early expressed in stroke.Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis.Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression
P2860
Q26740330-B90C0E54-89E2-4144-98C1-7231B5A0341EQ26773067-120452EB-D1D0-4F53-8712-52E5868A6F20Q26775932-D236BB74-3C90-42AD-8C4F-367F656A8E99Q26800426-73B82722-417F-420C-8EE8-6F6E1F1B0134Q28075913-9CCC9246-019E-47A2-A92A-DCF50837F9C4Q28386378-C080FD22-4F0C-48BA-B3C0-DE03ECAF2DDAQ28484900-EB662CD4-D810-466B-8792-9DC3D589B043Q28543041-30244856-C409-4369-B2F4-A1BD74EA5F2EQ28607691-B1D5EC95-F706-4166-AF39-6921CC14BE9DQ28821994-B6CA162C-53B9-4D4A-A0A4-E693D66950C1Q33887236-0F338560-F1DC-4DC6-98BD-1C434550F356Q34076322-315008A0-971C-45E5-AFC8-00D7EBADC39CQ34247391-C85E0E1E-E906-4504-902A-F127C79F392FQ34260092-88AB7B18-649F-4133-84E8-3C7714F0701DQ34345744-3DBA5977-E8FB-4B2C-8DEF-0EA444FB5C6CQ34381234-741204CB-AEAE-4198-9ED6-D62BCFA74250Q34556982-691F348C-6264-42F3-BCE4-7356EB526893Q34572320-13D30580-1365-4AF1-B848-8927C66BE5ACQ34695396-D0DA856E-0469-47E6-95F9-98EBF3768E07Q34997869-BFCC2C06-A214-4696-BF1E-F0A7A4A35CEFQ35121495-253DCEE3-2DF1-47C2-B4A7-5F1EAE7ED98DQ35592807-AAFF45B3-3551-4572-B28D-691D4BA58964Q35689877-A89D0BBC-C91E-4E34-8D2D-590260777817Q35788146-0CB803EA-5E2F-44CA-951C-BF026BCF5759Q35812916-1022A05F-69B5-4226-94B8-15D91B5B92CEQ36021394-FB1D57C9-B182-40D7-AEE9-8CEC3E61CCC5Q36108759-BA215628-E52B-4638-BE6C-E95078E06DA7Q36131465-8D428206-735B-4F68-98A5-85AF550D2F5AQ36634249-B71385E4-467B-40A0-B63D-35EE1E2D25C6Q36865674-9D05265E-A349-4F70-89B1-1C60BFD56AC1Q36870449-3B330593-2A2C-48FB-A105-E4F4F04571AFQ36901111-89E7B9C0-98AE-4F9D-9CA1-7647583EC5A3Q37011435-B86093DC-2042-460F-995E-3C75A6CAA8DCQ37013795-B180A6C1-CABB-4906-879D-311C8895648AQ37254521-5C737063-9D9D-4480-B7A4-2B16AD5C260AQ37342523-214FE542-674A-4D84-94FA-E54F657045C5Q37489173-EFAA82C3-952D-4A7C-BB2C-20E0B0E5082EQ37508208-18660A33-0F5A-4738-9893-233AF5BE75AEQ37602166-D36FF685-3C96-4627-9907-BE364A7D7450Q37623145-723E9CBD-68E2-4CE6-8328-3F406E13A354
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Quinolinic acid, the inescapable neurotoxin
@ast
Quinolinic acid, the inescapable neurotoxin
@en
Quinolinic acid, the inescapable neurotoxin
@nl
type
label
Quinolinic acid, the inescapable neurotoxin
@ast
Quinolinic acid, the inescapable neurotoxin
@en
Quinolinic acid, the inescapable neurotoxin
@nl
prefLabel
Quinolinic acid, the inescapable neurotoxin
@ast
Quinolinic acid, the inescapable neurotoxin
@en
Quinolinic acid, the inescapable neurotoxin
@nl
P2860
P3181
P1433
P1476
Quinolinic acid, the inescapable neurotoxin
@en
P2860
P304
P3181
P356
10.1111/J.1742-4658.2012.08485.X
P407
P577
2012-04-01T00:00:00Z